tradingkey.logo
tradingkey.logo
Search

aTyr Pharma Ord Shs

LIFE
Add to Watchlist
20.420USD
+0.150+0.74%
Close 07-31 16:00ETQuotes delayed by 15 min
1.29BMarket Cap
LossP/E TTM

More Details of aTyr Pharma Ord Shs Company

Ethos Technologies Inc. is a United States-based life insurance company. The Company offers whole life insurance and term life insurance. Its whole life insurance provides accidental death benefit and death benefit. Its term life insurance offers monthly payment of premiums that do not increase during the term. It is provided for age 65-85 years. Its term life insurance provides coverage for a term typically 10-30 years. The Company operates in every United States and the District of Columbia.

aTyr Pharma Ord Shs Info

Ticker SymbolLIFE
Company nameEthos Technologies Inc
IPO dateMay 07, 2015
CEOColis (Peter George)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endMay 07
Address1606 Headway Circle
CityAUSTIN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code78754
Phone13026365400
Websitehttps://www.ethos.com/
Ticker SymbolLIFE
IPO dateMay 07, 2015
CEOColis (Peter George)

Company Executives of aTyr Pharma Ord Shs

Name
Name/Position
Position
Shareholding
Change
Mr. Peter Colis
Mr. Peter Colis
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
900.00K
--
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, Director, President
Co-Founder, Director, President
900.00K
--
Mr. William J. (Bill) Wheeler
Mr. William J. (Bill) Wheeler
Independent Director
Independent Director
264.46K
-97.02%
Ms. Erin N. Lantz
Ms. Erin N. Lantz
Chief Revenue Officer
Chief Revenue Officer
253.90K
--
Mr. Vipul Sharma
Mr. Vipul Sharma
Chief Technology Officer
Chief Technology Officer
226.62K
+79.34%
Dr. Sanjay S. Shukla, M.D.
Dr. Sanjay S. Shukla, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
153.55K
+4.32%
Mr. Kunal Mehta
Mr. Kunal Mehta
Senior Vice President - Finance
Senior Vice President - Finance
128.16K
-19.88%
Mr. Timothy P. (Tim) Coughlin, CPA
Mr. Timothy P. (Tim) Coughlin, CPA
Independent Chairman of the Board
Independent Chairman of the Board
56.00K
+89.29%
Dr. Jane A. Gross, Ph.D.
Dr. Jane A. Gross, Ph.D.
Independent Director
Independent Director
9.75K
+38.46%
Dr. Svetlana Lucas, Ph.D.
Dr. Svetlana Lucas, Ph.D.
Independent Director
Independent Director
6.00K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Peter Colis
Mr. Peter Colis
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
900.00K
--
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, Director, President
Co-Founder, Director, President
900.00K
--
Mr. William J. (Bill) Wheeler
Mr. William J. (Bill) Wheeler
Independent Director
Independent Director
264.46K
-97.02%
Ms. Erin N. Lantz
Ms. Erin N. Lantz
Chief Revenue Officer
Chief Revenue Officer
253.90K
--
Mr. Vipul Sharma
Mr. Vipul Sharma
Chief Technology Officer
Chief Technology Officer
226.62K
+79.34%
Dr. Sanjay S. Shukla, M.D.
Dr. Sanjay S. Shukla, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
153.55K
+4.32%

FAQs

Who are the top five shareholders of aTyr Pharma Ord Shs?

The top five shareholders of aTyr Pharma Ord Shs are: Mr. Peter Colis

How many institutions hold shares of aTyr Pharma Ord Shs (LIFE)?

As of 2026Q1, 258 institutions hold shares of aTyr Pharma Ord Shs, with a combined market value of approximately 61.21M, accounting for 88.45% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -10216639.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.